Trial · NCT02793531
Anabolic Response Cancer
NCT02793531, Not applicable, Withdrawn, Texas A&M University
3 sourcestrials-2026-11-12-0.5.0
Cite this record
ConductScience Library. Anabolic Response Cancer. Trials, record NCT02793531. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT02793531
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- Anabolic Response Cancer
- NCT number
- NCT02793531
- Status
- Withdrawn
- Phases
- Not applicable
- Enrollment
- 0 participants, actual
- Lead sponsor
- Texas A&M University
- Conditions
- Cancer
- Interventions
- Stable isotope amino acid infusion
- First posted
- 2016-06-08
- Last updated
- 2018-03-22
Source ClinicalTrials.gov
Registered outcomes18
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Change in net whole-body protein synthesis | 0, 2, 5, 10, 15, 20, 30, 40, 50, 60, 90, 120, 150, 180, 210, 225, 240, 260, 280, 300, 320, 340, 360 ± 5 min | Change in whole-body protein synthesis rate after intake of meal |
| Secondary | Body Composition | 15 minutes on screening or study day 1 | Body composition as measured by Dual-Energy X-ray Absorptiometry |
| Secondary | Skeletal muscle strength | on study day 1 | handgrip |
| Secondary | Skeletal muscle strength | on study day 1 | kin-com 1-leg test |
| Secondary | Respiratory muscle strength | on study day 1 | Maximum inhalation and exhalation pressure |
| Secondary | Gut function | In postabsorptive and prandial state every 20 minutes up to 6 hours before each sip feeding on study day | Digestion of the stable tracers of amino acid |
| Secondary | Group differences in state of mood as measured by the Hospital Anxiety and Depression Scale (HADS) | Postabsorptive state during 3 hours and change after feeding on study day 1 | a fourteen item self-assessment scale. Seven of the items related to anxiety and seven relate to depression. Each item on the questionnaire is scored from 0-3 and this means that a person can score between 0 (no symptoms) and 21 (severe symptoms) for either anxiety or depression. |
| Secondary | Group differences in activity as measured by Physical Activity Scale for the Elderly (PASE) | Postabsorptive state during 3 hours and change after feeding on study day 1 | questionnaire is intended for use in an elderly population and focuses on 3 types of activities: leisure time activities, household activities and work-related activities. |
| Secondary | Group differences in state of mood as measured by the Profile of Mood State (POMS) | Postabsorptive state during 3 hours and change after feeding on study day 1 | A psychological distress scale to measure mood disturbance in 6 domains - fatigue-inertia, vigor-activity, tension-anxiety, depression-dejection, anger-hostility, and confusion-bewilderment. Healthy populations take 3 to 7 minutes to complete, and others may take up a bit longer. |
| Secondary | appetite questionnaire | study day 1 | The subject is asked to rate various aspects of their appetite as relates to overall health |
1 to 10 of 18Source ClinicalTrials.gov
See all 18 registered outcomesOutcomes0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
None in this release.
Results by group0
Each measurement the trial posted, group by group, in the words and numbers it posted.
None in this release.
Participant flow0
How many started, completed or left each group, period by period.
None in this release.
Adverse events0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
None in this release.
Adverse event totals0
The totals the trial posted for each group.
None in this release.
Papers0
The papers the trial lists on ClinicalTrials.gov.
None in this release.
Grants0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
None in this release.
Trial comparisons0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
None in this release.
Tests4
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
| Test | Named as | Source |
|---|---|---|
| Stroop Color-Word Test | Secondary outcome | ConductCognition |
| Trail Making Test A | Secondary outcome | ConductCognition |
| Verbal Fluency | Secondary outcome | ConductCognition |
| Verbal Learning | Secondary outcome | ConductCognition |
Data dates
The day each source was copied for this release.
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT02793531
GET https://conductscience.org/api/trials/v1/NCT02793531/registered